InvestorsHub Logo
icon url

Snowy_Owl

02/09/18 12:00 PM

#216771 RE: keltoi #216768

Kelt, I also think IPIX is on the verge of some type of deal. And I believe it is causing worry.

My first hint was when the newly recruited JV team began showing up late last year.
icon url

georgejjl

02/09/18 12:03 PM

#216773 RE: keltoi #216768

keltoi, I agree 100%

· The Confidential Disclosure Agreement (CDA) count toward partnering with global and specialty pharmaceutical companies interested in the Company’s first-in-class drug candidates is nearing 20, with additional Agreements in review. Successfully securing partnerships would afford the Company access to immediate and potentially recurring sources of non-dilutive capital, including upfront fees, milestone-based payments and tiered royalties;



http://www.ipharminc.com/press-release/2018/1/29/innovation-pharmaceuticals-brilacidin-franchise-anchored-in-three-clinical-indications-oral-mucositis-inflammatory-bowel-disease-and-serious-skin-infections-expands-into-dermatologic-diseases

Good luck and GOD bless,

George
icon url

sox040713

02/09/18 4:17 PM

#216822 RE: keltoi #216768

Not much “they” can do at this point. Just B alone has four licensing possibilities.

1. B-OM
2. B-UP
3. B-Dermatitis
4. B-ABSSSI